Press release
Hepatitis Diagnostic Tests Market Outlook Signals Expansion To $6.72 Billion Through 2030
Hepatitis Diagnostic Tests Market
Forecasted Growth and Size of the Hepatitis Diagnostic Tests Market
The market for hepatitis diagnostic tests is projected to reach a value of $6.72 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6%. This growth is largely driven by several factors including an increasing preference for decentralized diagnostic methods, heightened investments in advanced molecular testing technologies, the expansion of home-based testing options, and a growing emphasis on early detection of hepatitis. Additionally, the adoption of these tests is rising in resource-limited settings, further accelerating market expansion. Key trends anticipated through the forecast period include greater uptake of rapid diagnostic tests, wider use of molecular diagnostic technologies, integration of automated laboratory systems, increased availability of point-of-care testing, and a strong focus on delivering early and precise diagnoses.
The hepatitis diagnostic tests market size has grown strongly in recent years. It will grow from $4.93 billion in 2025 to $5.21 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to expansion of hepatitis screening programs, increased laboratory testing volumes, rising awareness of viral hepatitis, improved access to diagnostic infrastructure, availability of standardized testing protocols.
Download a free sample of the hepatitis diagnostic tests market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13153&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Top Market Participants Influencing the Hepatitis Diagnostic Tests Industry
Several prominent organizations are at the forefront of the hepatitis diagnostic tests market, including Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, and DIALAB GmbH.
Significant Acquisition Enhancing Market Portfolio
In October 2024, The Bank of Nova Scotia, headquartered in Canada, acquired Bio-Rad Laboratories for an undisclosed sum. This strategic acquisition aims to bolster The Bank of Nova Scotia's portfolio by integrating Bio-Rad Laboratories' expertise in hepatitis diagnostic testing products and services. Bio-Rad Laboratories Inc., a US-based company, is well-known for its contributions in the field of diagnostic testing for hepatitis, thereby strengthening the acquiring company's position in the market.
View the full hepatitis diagnostic tests market report:
https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Innovations and Emerging Trends Shaping the Hepatitis Diagnostic Tests Market
Leading companies in the hepatitis diagnostic space are focusing heavily on developing cutting-edge automated immunoassays designed to improve reliability and customer service. One such example is the Elecsys HCV Duo, an automated immunoassay that combines automation with sophisticated laboratory techniques to handle all stages of immunoassay testing, including sample preparation, reagent mixing, incubation, detection, and result calculation.
For instance, in July 2023, Roche Diagnostics India introduced the Elecsys HCV Duo, the first fully automated immunoassay in India capable of simultaneously and independently detecting hepatitis C virus (HCV) antigen and antibody levels from a single plasma or serum sample. This innovation streamlines the diagnostic process by enabling single specimen testing, reducing the number of patient visits for additional testing, and alleviating the strain on healthcare systems.
Understanding the Key Segments of the Hepatitis Diagnostic Tests Market
This report categorizes the hepatitis diagnostic tests market into several important segments:
1) Test Type:
- Blood Tests
- Imaging Tests
- Liver Biopsy
2) Technology Used:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Rapid Diagnostic Tests (RDTs)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Test (INAAT)
- Other Technologies
3) End-User Categories:
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Other End Users
Further detail is provided within subsegments such as:
- Blood Tests including Serological Tests, PCR Tests, and ELISA
- Imaging Tests covering Ultrasound, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI)
- Liver Biopsy techniques including Percutaneous, Transjugular, and Laparoscopic biopsies
These classifications provide a comprehensive overview of the types of tests, technologies, and users that define the hepatitis diagnostic tests market landscape.
Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis Diagnostic Tests Market Outlook Signals Expansion To $6.72 Billion Through 2030 here
News-ID: 4608376 • Views: …
More Releases from The Business Research Company
High Acuity Information Systems Market Report Examines Leading Companies And Gro …
The healthcare technology landscape is rapidly evolving, with high acuity information systems playing a pivotal role in enhancing patient care in critical settings. As hospitals and care centers increasingly adopt advanced digital tools, this market is set for remarkable growth. Let's explore the anticipated market size, leading players, key trends, and detailed segment insights shaping the future of high acuity information systems.
Projected Market Expansion of the High Acuity Information Systems…
Herpes Simplex Virus Treatment Market Outlook Highlights Strategic Opportunities …
The herpes simplex virus treatment market is set to witness substantial expansion in the coming years, driven by advances in antiviral therapies and increasing healthcare initiatives. With growing investments in research and a shift toward more patient-focused care, the industry is preparing for significant developments by 2030.
Projected Market Growth and Size of the Herpes Simplex Virus Treatment Market
The herpes simplex virus treatment market is on track to reach…
Hereditary Testing Market Study Explores Industry Growth Toward $10.17 Billion
The hereditary testing market is positioned for notable expansion as advancements in genomics and personalized medicine continue to gain momentum. Increasing integration of genetic insights into healthcare, along with technological innovations, are playing key roles in shaping this evolving industry. Here's an overview of the market's expected growth, leading companies, prominent trends, and crucial segments defining the hereditary testing landscape.
Projected Growth and Market Size of the Hereditary Testing Market …
Hereditary Angioedema Market Research Reveals Path To $4.14 Billion By 2030
The hereditary angioedema market is positioned for substantial expansion in the coming years, driven by advances in treatment options and an increased focus on personalized healthcare. As rare disease therapies continue to evolve alongside enhanced genetic screening techniques, the market is set to experience significant growth and innovation through 2030.
Projected Growth and Market Size of the Hereditary Angioedema Market
The hereditary angioedema market is anticipated to reach $4.15 billion…
More Releases for Dia
Octalsoft to Attend DIA 2025 Global Annual Meeting in Washington, DC
Herndon, VA - 12 June 2025 - Octalsoft is proud to announce its participation in the DIA 2025 Global Annual Meeting, taking place from June 15 to 19 in Washington, DC. This prestigious event brings together leading voices across regulatory, clinical, safety, and operational domains to address shared industry challenges and co-create the future of clinical research.
Representing Octalsoft at this year's gathering will be our Managing Director, Hiren Thakkar, who…
Welldon's Win At The Design Intelligence Award (DIA)
We are thrilled to announce that Welldon has been honored with the Design Intelligence Award (DIA), a highly prestigious international design competition.
Welldon's WD040 child safety seat stood out from over 8,000 entries, showcasing our innovation and commitment to child safety.
Image: https://ecdn6.globalso.com/upload/p/873/image_product/2024-10/1-1.jpg
What is the DIA?
The Design Intelligence Award (DIA) is China's first international academic award in the field of innovation design, launched in 2014. Supported by the Zhejiang Provincial Government and…
Food and Grocery Retailing Market 2022 Key Consumer Trends by Carrefour, Extra, …
"Food & grocery Retailing in Brazil, Market Shares, Summary and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Brazil retail environment. In addition, it analyzes the key consumer trends influencing Brazil food & grocery industry.
Food & grocery is the largest sector in the Brazilian retail industry, accounting for 53.9% of total retail sales. The…
Art Gallery Announces Dia Spriggs in Artist Showcase
Jupiter, FL, USA (October 19, 2013) -- Light Space & Time Online Art Gallery is very pleased to announce that wildlife artist Dia Spriggs is the gallery's newest featured artist. Her artworks will now be featured and promoted in gallery's Artist Showcase for the next 30 days.
Dia Spriggs is a self-taught wildlife artist living and creating her art in Florida. She lives with 13 cats, 2 dogs and 2 parrots,…
Meet MakroCare at 16th DIA CDM Japan Annual Workshop
DIA is conducting “16th Annual workshop in Japan for Clinical Data Management” conference in Tokyo, Japan from Feb 7-8, 2013 . Objectives of this workshop are to improve the quality of clinical research and data management activities. This annual workshop will provide information to attendees about the international clinical data management and attendees will get opportunities to network with colleagues in global Clinical Data Management. This workshop is expected…
MakroCare Launches EDC Application in Japanese Version at 15th DIA CDM Conferenc …
DDi (Drug Development informatics), a division of MakroCare, provides clinical products and technology solutions to the pharmaceutical, biotechnology and medical device companies.
DDi is releasing new Japanese edition “mEDC v2.0” in 15th DIA CDM Workshop in Japan. “mEDC v2.0” is a highly comprehensive configurable web-based electronic data capture application used for managing single or multi-site clinical research studies with complete audit trail.
Apart from mEDC, DDi brings other suite of applications specifically…
